Gossamer Bio Stock Probability of Future Stock Price Finishing Over 0.7
| GOSS Stock | USD 0.70 0.04 6.06% |
Gossamer |
Gossamer Bio Target Price Odds to finish over 0.7
The tendency of Gossamer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.70 | 90 days | 0.70 | about 98.0 |
Based on a normal probability distribution, the odds of Gossamer Bio to move above the current price in 90 days from now is about 98.0 (This Gossamer Bio probability density function shows the probability of Gossamer Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Gossamer Bio has a beta of 0.52. This usually indicates as returns on the market go up, Gossamer Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Gossamer Bio will be expected to be much smaller as well. Additionally Gossamer Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Gossamer Bio Price Density |
| Price |
Predictive Modules for Gossamer Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gossamer Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gossamer Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gossamer Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Gossamer Bio is not an exception. The market had few large corrections towards the Gossamer Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Gossamer Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Gossamer Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.41 | |
β | Beta against Dow Jones | 0.52 | |
σ | Overall volatility | 0.1 | |
Ir | Information ratio | -0.14 |
Gossamer Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Gossamer Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Gossamer Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Gossamer Bio generated a negative expected return over the last 90 days | |
| Gossamer Bio has some characteristics of a very speculative penny stock | |
| Gossamer Bio has high historical volatility and very poor performance | |
| Gossamer Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (179.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gossamer Bio currently holds about 304.38 M in cash with (159.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Gossamer Bio has a frail financial position based on the latest SEC disclosures | |
| Over 77.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Aranda Richard of 157500 shares of Gossamer Bio subject to Rule 16b-3 |
Gossamer Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Gossamer Stock often depends not only on the future outlook of the current and potential Gossamer Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gossamer Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 152.6 M | |
| Cash And Short Term Investments | 296.4 M |
Gossamer Bio Technical Analysis
Gossamer Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Gossamer Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Gossamer Bio. In general, you should focus on analyzing Gossamer Stock price patterns and their correlations with different microeconomic environments and drivers.
Gossamer Bio Predictive Forecast Models
Gossamer Bio's time-series forecasting models is one of many Gossamer Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Gossamer Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Gossamer Bio
Checking the ongoing alerts about Gossamer Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Gossamer Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Gossamer Bio generated a negative expected return over the last 90 days | |
| Gossamer Bio has some characteristics of a very speculative penny stock | |
| Gossamer Bio has high historical volatility and very poor performance | |
| Gossamer Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (179.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gossamer Bio currently holds about 304.38 M in cash with (159.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Gossamer Bio has a frail financial position based on the latest SEC disclosures | |
| Over 77.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Aranda Richard of 157500 shares of Gossamer Bio subject to Rule 16b-3 |
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.